Case Type: Mergers & Acquisitions

We are investigating National Commerce Corp. (“NCOM” or the “Company”) (NasdaqGS: NCOM) relating to the sale of the Company to CenterState Bank. As a result of the merger, NCOM shareholders are only anticipated to receive $40.01 per share.

We are investigating iPass Inc. (“iPass” or the “Company”) (NasdaqCM: IPAS) relating to the sale of the Company to Pareteum Corporation (“Pareteum”). As a result of the merger, iPass shareholders are only anticipated to receive 1.17 shares of Pareteum for each share of iPass stock owned.

We are investigating Investment Technology Group (“ITG” or the “Company”) (NYSE: ITG) relating to the sale of the Company to Virtu Financial, Inc.. As a result of the merger, ITG shareholders are only anticipated to receive $30.30 per share.

We are investigating Inuvo, Inc. (“Inuvo” or the “Company”) (NYSE American: INUV) relating to the sale of the Company to ConversionPoint Technologies, Inc. (“ConversionPoint”). As a result of the merger, Inuvo shareholders are only anticipated to receive $0.45 in cash and 0.18877 shares of ConversionPoint for each share of Inuvo stock that they own.

We are investigating Gaming Partners International Corporation. (“GPIC” or the “Company”) (NasdaqGM:GPIC) relating to the sale of the Company to Angel Holdings Godo Kaisha. As a result of the merger, GPIC shareholders are only anticipated to receive $13.75 in cash per share.

We are investigating FPB Financial Corp (“FPB” or the “Company”) (OTC:FPBF) relating to the sale of the Company to The First Bancshares, Inc. (“First Bancshares”). As a result of the merger, FPB shareholders are only anticipated to receive 0.83 shares of First Bancshares common stock.

We are investigating Finisar Corporation (“Finisar” or the “Company”) (NasdaqGS: FNSR) relating to the sale of the Company to II-VI Incorporated (“IIVI”). As a result of the merger, Finisar shareholders are only anticipated to receive $15.50 per share in cash and 0.2218 IIVI common shares for each share of Finisar that they own.

We are investigating Edge Therapeutics, Inc. (“Edge” or the “Company”) (NasdaqGS:EDGE) relating to the sale of the Company to PDS Biotechnology Corporation. As a result of the transaction, Edge Therapeutics shareholders will own 30% of the combined company.t

We are investigating BSB Bancorp, Inc. (“BSB” or the “Company”) (NasdaqCM:BLMT) relating to the sale of the Company to People’s United Financial, Inc. (“People’s United”). As a result of the merger, BSB shareholders are only anticipated to receive 2 shares of People’s United for each share of BSB they own.

We are investigating Bojangles’, Inc. (“Bojangles” or the “Company”) (NasdaqGS:BOJA) relating to the sale of the Company to Durational Capital Management LP and the Jordan Company. As a result of the merger, Bojangles’ shareholders are only anticipated to receive $16.10 per share.